Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir.
about
ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV InfectionErythropoietin rs1617640 G allele associates with an attenuated rise of serum erythropoietin and a marked decline of hemoglobin in hepatitis C patients undergoing antiviral therapyLimited utility of ITPA deficiency to predict early anemia in HCV patients with advanced fibrosis receiving Telaprevir.Telaprevir and ribavirin interaction: higher ribavirin levels are not only due to renal dysfunction during triple therapy.Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.Ribavirin steady-state plasma level is a predictor of sustained virological response in hepatitis C-infected patients treated with direct-acting antivirals.Pharmacogenetics of ribavirin-induced anemia in HCV patients.SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir.Patients treated with first-generation HCV protease inhibitors exhibit high ribavirin concentrations.Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.
P2860
Q28606732-C4A68C50-30D9-4B16-B1CF-AAE785E623AEQ34246440-C31CB24A-C864-429A-A165-177ADA98F437Q35156156-8AF85DE1-0305-41EA-AF18-C5F62347C2B9Q35607785-3F3C98A0-6A10-49CD-99D5-DDDED3DE516EQ38515906-9E7813DC-F0EB-4571-ADD4-D0828E7AC89FQ40053677-C71262EE-DFE8-44D4-97D6-117914706622Q40650428-6E568400-F600-4882-98D3-FB4C86BD0724Q41547430-5C39E93F-D943-40DB-AAE3-CD3CFFE6D6E9Q41655360-943921F8-9AC2-4801-B35E-DD6DFB1ACBD0Q55427239-8E592FD3-72A0-4811-8534-68534A5CD8DC
P2860
Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Significant early higher ribav ...... ron, ribavirin and telaprevir.
@en
Significant early higher ribav ...... ron, ribavirin and telaprevir.
@nl
type
label
Significant early higher ribav ...... ron, ribavirin and telaprevir.
@en
Significant early higher ribav ...... ron, ribavirin and telaprevir.
@nl
prefLabel
Significant early higher ribav ...... ron, ribavirin and telaprevir.
@en
Significant early higher ribav ...... ron, ribavirin and telaprevir.
@nl
P2093
P2860
P50
P356
P1476
Significant early higher ribav ...... ron, ribavirin and telaprevir.
@en
P2093
P2860
P304
P356
10.1111/JVH.12170
P577
2013-09-02T00:00:00Z